antimicrobial resistance
EpiEndo publishes new data supporting glasmacinal’s potential in COPD
June 13, 2025Medical Communications, Research and Development Chronic Diseases, EpiEndo Pharmaceuticals, Fraunhofer Institute for Toxicology and Experimental Medicine, antimicrobial resistance, chronic obstructive pulmonary disease (COPD), lung disease
EpiEndo Pharmaceuticals has announced the publication of three peer-reviewed articles in Pulmonary Pharmacology and Therapeutics, highlighting the therapeutic potential of …
Glox Therapeutics Awarded £1M PACE Grant to Accelerate Development of Precision Antibiotics Against Antimicrobial-resistant Pathogens
November 20, 2024AMR Week, Glox Therapeutics, antimicrobial resistance
Novel therapeutics to address unmet clinical need for pneumonias caused by drug-resistant Escherichia coli and Klebsiella pneumoniae PACE provides funding …
European Parliament shares goal to tackle antimicrobial resistance
June 2, 2023Medical Communications EU, European Parliament, Microbiology, antimicrobial resistance
The European Parliament has shared its recommendations for a “coordinated EU response to health threats posed by antimicrobial resistance,” according …
Is Pharma doing enough on sustainability?
July 20, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing antimicrobial resistance, manufacturing, pharma, sustainability
Adoption of sustainable practices in pharmaceutical operations is ticking along, but given the environmental and health risks if this is …
Industry comes together to form the AMR Action Fund, pledging $1bn to fight antimicrobial resistance
July 10, 2020Medical Communications, Research and Development AMR, antimicrobial resistance, biotech, pharma
Over 20 biopharma firms have come together to launch the AMR Action Fund, an initiative of the International Federation of …
The global rise in antibiotic resistance threatens infection prevention and cure
May 20, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing antibiotic resistance, antimicrobial resistance, feature, pharma
Dr Bill Love, Founder and Chief Scientific Officer of Destiny Pharma, discusses the rise of antimicrobial resistance (AMR), the antibiotic …
AMR advisor calls for public utility company to tackle AMR
March 28, 2019Medical Communications, Research and Development AMR, Lord Jim O'Neill, antimicrobial resistance, pharma, public health
Lord Jim O’Neill, an economist and former government advisor on antimicrobial resistance (AMR), has accused the pharmaceutical industry of “spewing …
Destiny Pharma secures £1.6m grant to fight ‘superbugs’ and antimicrobial resistance
January 29, 2019Manufacturing and Production, Research and Development Destiny Pharma, antimicrobial resistance, pharma
UK biotech Destiny Pharma has secured £1.6 million in funding to further its research into the prevention and elimination of …
AMR superbugs expected to kill 90,000 Britons in the next 30 years
November 8, 2018Research and Development AMR, antimicrobial resistance, infectious diseases, spanish flu
Antibiotic resistant superbugs will kill more than 90,000 British people over the next thirty years if action is not taken …
UK government accused of using Brexit to avoid antimicrobial resistance ruling
September 28, 2018Medical Communications AMR, Antibiotics, UK, WHO, antimicrobial resistance, farming, politics
The British government has been accused of using Brexit to avoid implementing new EU legislation preventing powerful antibiotics from be …
Trump administration resists WHO efforts to tackle antimicrobial resistance
August 31, 2018Medical Communications AMR, Trump, US, US government, WHO, antimicrobial resistance
The Trump administration is in the process of drafting an alternative to the World Health Organization’s guidelines on the use …
Top Ten most popular articles on Pharmafile.com this week
July 27, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Amgen, China, GSK, Gilead, J&J, JJ, Pfizer, Remicade, Roche, antimicrobial resistance, biosimilar, pharma, pricing, viagra
With the UK in the grip of a record-breaking heatwave, it’s hard to focus on much else over here, but …
The mission against antimicrobial resistance
July 23, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing antibiotic resistance, antimicrobial resistance, feature, pharma
Two headlines have highlighted the ‘here and now’ of the threat of rising antimicrobial resistance (AMR), writes Dr Peter Jackson.A …
NICE calls to limit antibiotic use in COPD over antimicrobial resistance fears
July 10, 2018Manufacturing and Production, Medical Communications, Research and Development COPD, NICE, antimicrobial resistance, chronic obstructive pulmonary disease, pharma
NICE have published a draft antimicrobial prescribing guide recommending that healthcare professionals should consider the risk of antimicrobial resistance when …
64% of FDC antibiotics in India are unapproved, report reveals
February 5, 2018Manufacturing and Production, Sales and Marketing Antibiotics, India, antimicrobial resistance, pharma
The majority of fixed dose combination (FDC) antibiotics that are made and sold in India are still unapproved, despite promises …
